Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.

Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van den Born J, Navis G, de Borst MH.

PLoS One. 2013;8(2):e55887. doi: 10.1371/journal.pone.0055887. Epub 2013 Feb 11.

2.

Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.

de Borst MH, Nauta FL, Vogt L, Laverman GD, Gansevoort RT, Navis G.

PLoS One. 2012;7(5):e37957. doi: 10.1371/journal.pone.0037957. Epub 2012 May 25.

3.

Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.

Shoukry A, Bdeer Sel-A, El-Sokkary RH.

Mol Cell Biochem. 2015 Oct;408(1-2):25-35. doi: 10.1007/s11010-015-2479-y. Epub 2015 Jun 24.

PMID:
26104579
4.

Exposure to hydrocarbons and renal disease: an experimental animal model.

Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozzoni P, Nonclercq D, Bernard A, Manzo L.

Ren Fail. 1999 May-Jul;21(3-4):369-85.

PMID:
10416216
5.

Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.

Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van Goor H, Navis G.

Am J Physiol Renal Physiol. 2009 May;296(5):F1136-45. doi: 10.1152/ajprenal.00541.2007. Epub 2009 Feb 18.

6.

Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.

Nauta FL, Bakker SJ, van Oeveren W, Navis G, van der Heide JJ, van Goor H, de Jong PE, Gansevoort RT.

Am J Kidney Dis. 2011 May;57(5):733-43. doi: 10.1053/j.ajkd.2010.12.022. Epub 2011 Apr 1. Erratum in: Am J Kidney Dis. 2011 Sep;58(3):500-1.

PMID:
21458900
7.

Progression of chronic adriamycin nephropathy in leukopenic rats.

Ginevri F, Trivelli A, Mutti A, Bergamaschi E, Fabbretti G, Callea F, Salvidio G, Altieri P, Perfumo F, Ghiggeri GM.

Nephron. 1993;63(1):79-88.

PMID:
8446256
9.

Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.

Kramer AB, Ricardo SD, Kelly DJ, Waanders F, van Goor H, Navis G.

J Pathol. 2005 Dec;207(4):483-92.

PMID:
16211543
10.

Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.

Taniguchi H, Kojima R, Sade H, Furuya M, Inomata N, Ito M.

J Clin Immunol. 2007 Jul;27(4):409-29. Epub 2007 May 22.

PMID:
17516154
11.

Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.

de Borst MH, van Timmeren MM, Vaidya VS, de Boer RA, van Dalen MB, Kramer AB, Schuurs TA, Bonventre JV, Navis G, van Goor H.

Am J Physiol Renal Physiol. 2007 Jan;292(1):F313-20. Epub 2006 Aug 8.

12.
13.

Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis.

Shu Y, Hoshi S, Tomari S, Watanabe T, Nagata M.

Pathol Int. 2002 Mar;52(3):214-23.

PMID:
11972865
14.

[Correlation between urinary biomarkers and pathological lesions in drug-induced tubulointerstitial nephritis].

Wu Y, Su T, Yang L, Wang C, Liu G, Li XM.

Zhonghua Nei Ke Za Zhi. 2010 Jul;49(7):568-71. Chinese.

PMID:
20979765
15.

Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.

Yazdani S, Hijmans RS, Poosti F, Dam W, Navis G, van Goor H, van den Born J.

Dis Model Mech. 2015 Aug 1;8(8):919-30. doi: 10.1242/dmm.018580. Epub 2015 May 14.

16.
17.

Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies.

Dantas M, Romão EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, Ravinal RC, Rodrigues Júnior AL, Coimbra TM.

Kidney Blood Press Res. 2007;30(5):306-13. Epub 2007 Sep 5.

18.

Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.

Vieira JM Jr, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, Fujihara CK, Zatz R.

Nephrol Dial Transplant. 2005 Aug;20(8):1582-91. Epub 2005 Apr 26.

PMID:
15855201
19.

Renal disorders involved in the pathophysiology of urinary excretion of a-1 microglobulin in patients with glomerulopathies.

Romão EA, Coimbra TM, Costa RS, Vieira Neto OM, Reis MA, Rodrigues Júnior AL, Ribeiro RA, Ravinal RC, Dantas M.

Clin Nephrol. 2009 Dec;72(6):473-81.

PMID:
19954725
20.

Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease.

Nabity MB, Lees GE, Dangott LJ, Cianciolo R, Suchodolski JS, Steiner JM.

Vet Clin Pathol. 2011 Jun;40(2):222-36. doi: 10.1111/j.1939-165X.2011.00307.x. Epub 2011 Mar 29.

PMID:
21446987

Supplemental Content

Support Center